Levophacetoperane
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Clinical data | |
---|---|
Routes of administration |
Oral |
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
|
|
CAS Number | 24558-01-8 Y |
PubChem (CID) | 15706387 |
ChemSpider | 32702188 |
UNII | 3SZ9ZII529 |
Chemical and physical data | |
Formula | C14H19NO2 |
Molar mass | 233.31 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Levophacetoperane (Lidépran, Phacétoperane) is a psychostimulant developed by Rhône-Poulenc in the 1950s.[1] The drug has been used as an antidepressant and anorectic.[2][3] It is the reverse ester of methylphenidate.
See also[edit]
References[edit]
- ^ Joseph Nicole Marie; Jacob Robert Michel (15 March 1960). "Patent US 2928835 - New esters". Rhône-Poulenc.
- ^ Delbeke, F. T.; Debackere, M. (26 March 1975). "Isolation and detection of methylphenidate, phacetoperane and some other sympatomimetic central nervous stimulants with special reference to doping". Journal of Chromatography A. 106 (2): 412–417. doi:10.1016/S0021-9673(00)93853-6. PMID 239015 – via ScienceDirect.
- ^ Eric Konofal; Bruno Figadere (5 February 2015). "Patent Application US 20150038533 - Phacetoperane for the treatment of attention-deficit hyperactivity disorder". Assistance Publique – Hôpitaux de Paris.
Central |
|
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Peripheral | |||||||||||
|
α1 |
|
||||||
---|---|---|---|---|---|---|---|
α2 |
|
||||||
β |
|
||||||
D1-like |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D2-like |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |